CoChat

Stereoisomers of Schisandrin B Are Potent ATP Competitive GSK-3β Inhibitors with Neuroprotective Effects against Alzheimer’s Disease: Stereochemistry and Biological Activity

Hu, Xiao-Long, Guo, Cui, Hou, Ji-Qin, Feng, Jia-Hao, Zhang, Xiao-Qi, Xiong, Fei, Ye, Wen-Cai, Wang, Hao · 2019 · ACS Chemical Neuroscience

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

Glycogen synthase kinase-3β (GSK-3β) is a key enzyme in hyperphosphorylation of tau proteins and is a promising therapeutic target in Alzheimer’s disease (AD). Here, we reported, for the first time, that the stereoisomers of Schisandrin B (Sch B), (+)- 1, (−)- 1, (+)- 2, and (−)- 2, were potent GSK-3β inhibitors. They were demonstrated to selectively target GSK-3β in an orthosteric binding mode, with IC 50 values of 340, 290, 80, and 70 nM, respectively. Further study showed that these stereoisomers can significantly increase the expression of p-GSK-3β (Ser9) and decrease the expressions of p-GSK-3β (Tyr216) and p-GSK-3β (Tyr279). Finally, these compounds can alleviate the cell injury induced by Aβ, and the cognitive disorders in AD mice, especially (+)- 2 and (−)- 2 . Collectively, the stereoisomers of Sch B, especially (+)- 2 and (−)- 2, were found to be potential selective ATP-competitive GSK-3β inhibitors, which further affected their anti-AD effects. These promising findings explained the biological target of Sch B in AD, and bring a new understanding in the stereochemistry and bioactivities of Sch B.

Overview

Integrity signals

Registry

Crossref · 10.1021/acschemneuro.8b00252

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 1

  1. Rester U., 2008, Curr. Opin. Drug Discovery Dev., 11, 559

Cited by

See all 40

Metadata

Authors
Hu, X.-L., Guo, C., Hou, J.-Q., Feng, J.-H., Zhang, X.-Q., Xiong, F., Ye, W.-C., & Wang, H.
Affiliations
  • State Key Laboratory of Natural Medicines, Department of TCMs Pharmaceuticals, School of Traditional Chinese Pharmacy. China Pharmaceutical University, Nanjing 210009, People’s Republic of China
  • China Pharmaceutical University (CN)
  • Jinan University (CN)
  • State Key Laboratory of Digital Medical Engineering (CN)
Corresponding author
Wang, Hao
Venue
ACS Chemical Neuroscience
Published
2018-06-26
Volume
10
Issue
2
Pages
996-1007
ISSN
1948-7193 (ISSN-L)
OpenAlex
W2810868902
Cited by
39
References
40
Citations by year
2026: 4 · 2025: 4 · 2024: 9 · 2023: 5 · 2022: 7 · 2021: 4 · 2020: 4 · 2019: 2
FWCI
1.72
Type
journal article
Language
en
Open access
closed
Locations
  • ACS Chemical Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Government of Jiangsu Province (KYCX17_0694, KYLX15_0661)
  • National Natural Science Foundation of China (81473160, 81573309)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Plant-derived Lignans Synthesis and Bioactivity
Keywords
schisandrin B, stereoisomers, GSK-3β inhibitors, ATP-competitive inhibition, Alzheimer's disease, neuroprotection, orthosteric binding, tau hyperphosphorylation, amyloid-beta toxicity, cognitive impairment
MeSH terms
Glycogen Synthase Kinase 3 beta, Adenosine Triphosphate, Alzheimer Disease, Animals, Cell Survival, Enzyme Inhibitors, Hippocampus, Humans, Male, Mice, Inbred ICR, Polycyclic Compounds, Stereoisomerism, Treatment Outcome, Lignans, Neuroprotective Agents, Cyclooctanes, Cell Line, Tumor, Mice, Molecular Docking Simulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.